Immunosurveillance of alveolar echinococcosis by specific humoral and cellular immune tests: Long-term analysis of the Swiss chemotherapy trial (1976-2001)

Journal of Hepatology

Volumn 41, Issue 4, 2004, Pages 551-559

  Ammann, Rudolf W ^a   Renner, Elisabeth C ^a   Gottstein, Bruno ^b   Grimm, Felix ^c   Eckert, Johannes ^c   Renner, Eberhard L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

AE long term study; AE recurrence after radical surgery; Clinical impact of immune profile; Presumed parasitocidal chemotherapy

Indexed keywords

BENZIMIDAZOLE; MEBENDAZOLE;

ADULT; AGED; ANTHELMINTIC ACTIVITY; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CELL MEDIATED LYMPHOLYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFICACY; EARLY DIAGNOSIS; ECHINOCOCCOSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGICAL TECHNIQUE; IMMUNOSURVEILLANCE; LIVER HYDATID CYST; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DOCUMENTATION; PATIENT MONITORING; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL RATE;

ADULT; AGED; ANTIBODIES, HELMINTH; ANTIBODY FORMATION; ANTICESTODAL AGENTS; ANTIGENS, SURFACE; ECHINOCOCCOSIS, PULMONARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, CELLULAR; MALE; MEBENDAZOLE; MIDDLE AGED; MONITORING, IMMUNOLOGIC; PROSPECTIVE STUDIES; PULMONARY ALVEOLI; RECURRENCE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 4644279855     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.06.015     Document Type: Article

References (36)

1. P.M. Schantz, H. Van den Bosche, and J. Eckert Chemotherapy for larval echinococcosis in animals and humans: report of a workshop Z Parasitenk 67 1982 5 26
2. R.W. Ammann, and J. Eckert Cestodes echinococcus Gastroenterol Clin N Am 25 1996 655 689
3. P. Kern, W. Kratzer, and S. Reuter Alveoläre echinokokkose: therapie Dtsch Med Wochenschr 125 2000 87 89
4. WHO: Guidelines for treatment of cystic and alveolar echinococcosis in humans WHO informal Working Group on Echinococcosis Bull WHO 74 1996 231 242
5. R.W. Ammann, A. Fleiner-Hoffmann, and J. Eckert Schweizerische Studie für Chemotherapie der alveolären Echinokokkose-Rückblick auf ein 20-jähriges klinisches Forschungsprojekt Schweiz Med Wochenschr 129 1999 323 332
6. R.W. Ammann, N. Ilitsch, B. Marincek, and A.U. Freiburghaus Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis Hepatology 19 1994 735 742
7. Z.S. Pawlowski, J. Eckert, D.A. Vuittton, R.W. Ammann, P. Kern, and P.S. Craig Echinococcosis in humans: clinical aspects, diagnosis and treatment J. Eckert M.A. Gemmell F.X. Meslin Z.S. Pawlowski WHO/OIE Manual on echinococcosis in humans and animals 2001 World Organisation for Animal Health and WHO Paris 20 71
8. J. Eckert Prospects for treatment of the metcestode stage of echinococcus R.C.A. Thompson The biology of echinococcus and hydatid disease 1986 George Allen and Unwin London 250 284
9. R.W. Ammann, R. Hirsbrunner, J. Cotting, U. Steiger, P. Jacquier, and J. Eckert Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis Am J Trop Med Hyg 43 1990 506 515
10. J.F. Wilson, R.L. Rausch, B.J. McMahon, and P.M. Schantz Parasitocidal effect of chemotherapy in alveolar hydatid disease:review of experience with mebendazole and albendazole in Alascan Eskimos Clin Infect Dis 15 1992 234 249
11. R.W. Ammann, A. Fleiner-Hoffmann, F. Grimm, and J. Eckert Long-term mebendazole therapy may be parasitocidal in alveolar echinococcosis J Hepatol 29 1998 994 998
12. M.W. Lightowlers, and B. Gottstein Echinococcosis/hydatidosis: antigens, immunological and molecular diagnosis R.C.A. Thompson A.J. Lymbery Echinococcus and hydatid disease 1995 CAB International Wallingford, UK 355 410
13. Y. Sako, M. Nakao, K. Nakayo, H. Yamasaki, B. Gottstein, and M.W. Lighttowers Alveolar echinococcosis: characterization of diagnotic antigen Em 18 and serological evaluation of recombinant Em 18 J Clin Microbiol 40 2002 2760 2765
14. R. Felleisen, and B. Gottstein Echinococcus multilocularis: molecular and immunochemical characterization of diagnostic antigen II/3-10 Parasitology 107 1993 335 342
15. L. Ma, A. Ito, Y.H. Liu, X.G. Wang, Y.Q. Yao, and D.G. Yu Alveolar echinococcosis: Em2 plus-ELISA and Em 18-western blots for follow-up after treatment with albendazole Trans R Soc Trop Med Hyg 91 1997 476 478
16. K. Hubert, R. Zavala-Gongora, M. Frosch, and K. Brehm Identification and characterization of PDZ-1, a N-ERMAD specific interaction partner of the echinococcus multilocularis ERM protein Elp Mol Biochem Parasitol 134 2004 149 154
17. B. Gottstein, B. Mesarina, I. Tanner, R.W. Ammann, J.F. Wilson, and J. Eckert Specific cellular and humoral immune responses in patients with different long-term courses of alveolar echinococcosis Am J Trop Med Hyg 45 1991 734 742
18. B. Gottstein, K. Tschudi, J. Eckert, and R.W. Ammann Em-2-ELISA for the follow-up of alveolar echinococcosis after complete surgical resection of liver lesions Trans R Soc Trop Med Hyg 83 1989 389 393
19. A. Eger, A. Kirch, B. Manfras, P. Kern, H. Schultz-Key, and P.T. Soboslay Pro-inflammatory (IL-1 beta, IL-18) cytpkines and IL-8 chemokine release by PBMC in response to echinococcus multilocularis metacestode vesicles Parasite Immunol 25 2003 103 105
20. F. Mosimann Is alveolar hydatid of the liver incurable? Ann Surg 192 1980 118 123
21. S. Reuter, B. Jensen, K. Buttenschoen, W. Kratzer, and P. Kern Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature J Antimicrobiol Chemother 46 2000 451 456
22. S. Bresson-Hadni, S. Koch, I. Beurton, D.A. Vuitton, B. Bartholomot, and S. Hrusovsky Primary disease recurrence after liver transplantation for alveolar echinococcosis: long-term evaluation in 15 patients Hepatology 30 1999 857 864
23. E.M. Sarciron, S. Bresson-Hadni, M. Mercier, P. Lawton, C. Duranton, and D. Lenys Antibodies against echinococcus multilocularis alkaline phosphatase as markers for the specific diagnosis and the serological monitoring of alveolar echinococcosis Parasite Immunol 19 1997 61 68
24. B. Gottstein, and A. Hemphill Immunopathology of echinococcosis Chem Immunol 66 1997 177 208
25. L. Nicod, S. Bresson-Hadni, D.A. Vuitton, I. Emery, B. Gottstein, and H. Aver Specific cellular and humoral immune responses induced by different antigen preparations of echinococcus multilocularis metacestodes in patients with alveolar echinococcosis Parasite 1 1994 261 270
26. W.J. Dai, A. Hemphill, A. Waldvogel, K. Ingold, P. Deplazes, and H. Moss-mann Major carbohydrate antigen of echinococcus multilocularis induces an immunoglobulin G response independent of CD 4 T-cells Infect Immun 69 2001 6074 6083
27. C.M. Dreweck, P.T. Soboslay, H. Schulz-Key, B. Gottstein, and P. Kern Cytokine and chemokine secretion by human peripheral blood cells in response to viable echinococcus multilocularis metacestode vesicles Parasite Immunol 21 1999 433 438
28. D. Sturm, J. Menzel, B. Gottstein, and P. Kern Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis Infect Immun 63 1995 1688 1697
29. V. Godot, S. Harraga, I. Beurton, M. Deschaseaux, E. Sarciron, and B. Gottstein Resistance/susceptibility to echinococcus multilocularis infection and cytokine profile in humans Clin Exp Immunol 121 2000 484 490
30. N. Wellinghausen, P. Gebert, and P. Kern Interleukin (IL)-4 and IL-12-profile in serum of patients with alveolar echinococcosis Acta Trop 73 1999 165 174
31. V. Godot, S. Harraga, G. Podoprigora, M. Liance, K. Bardonnet, and J.A. Vuitton IFN-2a protects mice against a helminth infection of the liver and modulates immune response Gastroenterology 124 2003 1441 1450
32. F. Witassek, B. Burkhardt, J. Eckert, and J. Bircher Chemotherapy of alveolar echinococcosis Eur J Clin Pharmacol 20 1981 427 433
33. W. Woodtli, J. Bircher, F. Witassek, J. Eckert, B. Wüthrich, and R.W. Ammann Effect of plasma mebendazole concentrations in the treatment of human echinococcosis Am J Trop Med Hyg 34 1985 754 760
34. P.J. Luder, B. Siffert, F. Witassek, F. Meister, and J. Bircher Treatment of hydatid disease with high oral doses of mebendazole Eur J Clin Pharmacol 31 1986 443 448
35. S. Reuter, H. Schirmeister, W. Kratzer, C. Dreweck, S.N. Reske, and P. Kern Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography Clin Infect Dis 29 1999 157 163
36. S. Reuter, A. Buck, B. Manfras, W. Kratzer, H.M. Seitz, and K. Darge Structural treatment interruption in patients with alveolar echinococcosis Hepatology 39 2004 509 517